Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

74
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
74

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and safety of rapid glofitamab ramp-up.

Leukemia·2026
Same author

Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.

Blood cancer journal·2026
Same author

Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor.

Nature communications·2026
Same author

Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma.

Nature cancer·2026
Same author

Burkitt Lymphoma-A Guide to Biological Features, Diagnosis and Differential Diagnosis.

Cancers·2026
Same author

Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Blood advances·2026

Related Experiment Video

Updated: Aug 15, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.4K

Molecular profiling of EBV associated diffuse large B-cell lymphoma.

Fabian Frontzek1, Annette M Staiger2,3, Ramona Wullenkord1

  • 1Department of Medicine A, Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.

Leukemia
|January 5, 2023
PubMed
Summary

Epstein-Barr virus (EBV) positive diffuse large B-cell lymphoma (DLBCL) has a unique biology, with most cases not fitting established subtypes. Key mutations and amplifications were identified, offering potential therapeutic targets for this aggressive cancer.

More Related Videos

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.8K
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.0K

Related Experiment Videos

Last Updated: Aug 15, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.4K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.8K
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.0K

Area of Science:

  • Hematology
  • Oncology
  • Virology

Background:

  • Epstein-Barr virus (EBV) is linked to various lymphomas, but its role in diffuse large B-cell lymphoma (DLBCL) and its molecular features remain unclear.
  • EBV-associated DLBCL is a rare, aggressive subtype with poor clinical outcomes.

Purpose of the Study:

  • To comprehensively analyze the molecular characteristics of EBV-positive DLBCL.
  • To identify specific genetic aberrations driving lymphomagenesis and immune evasion in EBV+ DLBCL.

Main Methods:

  • Targeted sequencing of cancer candidate genes (CCGs) in 60 primary EBV+ DLBCL samples.
  • Genome-wide analysis of recurrent somatic copy number alterations (SCNAs) in 46 cases.
  • Application of the LymphGen classifier 2.0 for molecular subtyping.

Main Results:

  • Less than 20% of EBV+ DLBCLs aligned with established molecular DLBCL subtypes, indicating a distinct biology.
  • Recurrent mutations activating JAK-STAT and NOTCH pathways were identified.
  • Frequent amplifications at 9p24.1 leading to PD-L1 overexpression and immune escape were observed.

Conclusions:

  • EBV+ DLBCL represents a unique molecular entity within DLBCL.
  • Identified genetic aberrations, including JAK-STAT and NOTCH pathway activations and 9p24.1 amplifications, provide potential therapeutic targets.
  • Further research into targeting these specific molecular alterations may improve outcomes for patients with EBV+ DLBCL.